BioGend Therapeutics Co., Ltd. (TPEX:6733)
26.35
+0.35 (1.35%)
At close: Jul 9, 2026
-12.17% (1Y)
| Market Cap | 3.28B -14.5% |
| Revenue (ttm) | 229.81M +28.0% |
| Net Income | -67.11M |
| EPS | -0.55 |
| Shares Out | 124.36M |
| PE Ratio | n/a |
| Forward PE | n/a |
| Dividend | n/a |
| Ex-Dividend Date | n/a |
| Volume | 190,191 |
| Open | 26.65 |
| Previous Close | 26.00 |
| Day's Range | 26.00 - 26.75 |
| 52-Week Range | 23.45 - 49.15 |
| Beta | 0.09 |
| Analysts | n/a |
| Price Target | n/a |
| Earnings Date | Aug 7, 2026 |